Search

Melialani Anderson Phones & Addresses

  • Corvallis, OR
  • Newberg, OR

Work

Company: Andersen construction Jan 2020 Position: Estimator

Education

School / High School: Oregon State University 2014 to 2015 Specialities: Pharmacy

Skills

Drug Discovery • Pharmaceutical Industry • Molecular Biology • Assay Development • Biotechnology • Formulation Chemistry • Drug Development • Glp • Elisa • Formulation • Dissolution • High Throughput Screening • Stability Studies • Tissue Culture • Infectious Diseases • Solubility • In Vivo • Virology • Cell Culture • Laboratory Skills • Hplc • Drug Substance and Product Development • Drug Substance Polymorph Analysis • Microbiology • Chemistry • Clinical Development • Clinical Research • Fda • Validation • Analytical Chemistry • Organic Chemistry • Sop • Pcr • Contracts Administrators • Contract Management • Subcontracts Management • New Hire Paperwork • Payroll • Certified Payroll Reports • Accounts Payable • Invoice Processing • Oracle Database • Notary Public • Mwesb • Leadership In Energy and Environmental D... • Leed Projects • Project Closeout

Ranks

Certificate: Notary Public

Industries

Construction

Professional Records

Lawyers & Attorneys

Melialani Anderson Photo 1

Melialani Athena Anderson

Resumes

Resumes

Melialani Anderson Photo 2

Estimator

View page
Location:
Eugene, OR
Industry:
Construction
Work:
Andersen Construction
Estimator

Siga Technologies May 2006 - Nov 2013
Research Associate Iii
Education:
Oregon State University 2014 - 2015
Oregon State University 2001 - 2006
Bachelors, Bachelor of Science, Forensic Science, Microbiology, Chemistry
Skills:
Drug Discovery
Pharmaceutical Industry
Molecular Biology
Assay Development
Biotechnology
Formulation Chemistry
Drug Development
Glp
Elisa
Formulation
Dissolution
High Throughput Screening
Stability Studies
Tissue Culture
Infectious Diseases
Solubility
In Vivo
Virology
Cell Culture
Laboratory Skills
Hplc
Drug Substance and Product Development
Drug Substance Polymorph Analysis
Microbiology
Chemistry
Clinical Development
Clinical Research
Fda
Validation
Analytical Chemistry
Organic Chemistry
Sop
Pcr
Contracts Administrators
Contract Management
Subcontracts Management
New Hire Paperwork
Payroll
Certified Payroll Reports
Accounts Payable
Invoice Processing
Oracle Database
Notary Public
Mwesb
Leadership In Energy and Environmental Design
Leed Projects
Project Closeout
Certifications:
Notary Public
Procore Certified: Project Manager (Quality & Safety)
Procore Certified: Project Manager (Core Tools)
Procore Certified: Project Manager (Project Management)

Publications

Us Patents

St-246 (Tecovirimat Monohydrate) Suspension Formulations

View page
US Patent:
20230016581, Jan 19, 2023
Filed:
Jul 14, 2022
Appl. No.:
17/864909
Inventors:
- Corvallis OR, US
Kris HOLT - Colorado Springs CO, US
Ying TAN - Millbrae CA, US
Melialani A.C.L.S. ANDERSON - Corvallis OR, US
Dennis E. HRUBY - Albany OR, US
Assignee:
SIGA TECHNOLOGIES, INC. - Corvallis OR
International Classification:
A61K 31/403
A61K 9/00
A61K 9/16
A61K 47/26
A61K 47/34
A61K 47/38
Abstract:
The present invention is directed to a dry suspension for reconstitution containing Tecovirimat (ST-246) powder and simethicone. The dry suspension is dispersed in water to provide an aqueous pharmaceutical suspension formulation for oral administration for treating orthopoxvirus infections and/or eczema vaccinatum. The suspension formulation exhibits excellent stability and good dissolution and has an improved taste and texture.

St-246 (Tecovirimat Monohydrate) Suspension Formulations

View page
US Patent:
20210212987, Jul 15, 2021
Filed:
Feb 15, 2017
Appl. No.:
16/071119
Inventors:
- Corvallis OR, US
Kris HOLT - Colorado Springs CO, US
Ying TAN - Millbrae CA, US
Melialani A.C.L.S. ANDERSON - Corvallis OR, US
Dennis E. HRUBY - Albany OR, US
Assignee:
SIGA TECHNOLOGIES, INC. - Corvallis OR
International Classification:
A61K 31/403
A61K 47/34
A61K 47/38
A61K 47/26
A61K 9/16
A61K 9/00
Abstract:
The present invention is directed to a dry suspension for reconstitution containing Tecovirimat (ST-246) powder and simethicone. The dry suspension is dispersed in water to provide an aqueous pharmaceutical suspension formulation for oral administration for treating orthopoxvirus infections and/or eczema vaccinatum. The suspension formulation exhibits excellent stability and good dissolution and has an improved taste and texture.

Polymorphic Forms Of St-246 And Methods Of Preparation

View page
US Patent:
20210137885, May 13, 2021
Filed:
Dec 29, 2020
Appl. No.:
17/136674
Inventors:
- Corvallis OR, US
Melialani A.C.L.S. ANDERSON - Corvallis OR, US
William C. WEIMERS - Corvallis OR, US
Dylan NELSON - Corvallis OR, US
Dennis E. HRUBY - Albany OR, US
Michael H. O'NEILL - Painesville OH, US
Gary SWEETAPPLE - Madison OH, US
Kelley A. McCLOUGHAN - South Haven MI, US
Assignee:
Siga Technologies, Inc. - Corvallis OR
International Classification:
A61K 31/404
C07D 209/76
A61K 9/16
A61K 9/48
C07D 209/70
Abstract:
Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.

St-246 Liquid Formulations And Methods

View page
US Patent:
20200138974, May 7, 2020
Filed:
Jan 2, 2020
Appl. No.:
16/732509
Inventors:
- Corvallis OR, US
Melialani A.C.L.S. ANDERSON - Corvallis OR, US
William WEIMERS - Corvallis OR, US
Gopi Krishna KASI - Lynnwood WA, US
N K Peter SAMUEL - Corvallis OR, US
Tove C. Bolken - Keizer OR, US
Dennis E. HRUBY - Albany OR, US
Assignee:
SIGA TECHNOLOGIES, INC. - Corvallis OR
International Classification:
A61K 47/69
A61K 47/26
A61K 9/08
A61K 31/724
A61K 31/715
A61K 47/40
A61K 47/10
A61K 9/00
A61K 31/4035
Abstract:
The present invention provides for a novel liquid formulation for solubilizing poorly soluble ST-246 in cyclodextrins and a novel process of making the formulation.

Polymorphic Forms Of St-246 And Methods Of Preparation

View page
US Patent:
20190343799, Nov 14, 2019
Filed:
Jul 24, 2019
Appl. No.:
16/520897
Inventors:
- Corvallis OR, US
Melialani A.C.L.S. ANDERSON - Corvallis OR, US
William C. WEIMERS - Corvallis OR, US
Dylan NELSON - Corvallis OR, US
Dennis E. HRUBY - Albany OR, US
Michael H. O'NEILL - Painesville OH, US
Gary SWEETAPPLE - Madison OH, US
Kelley A. McCLOUGHAN - South Haven MI, US
Assignee:
Siga Technologies, Inc. - Corvallis OR
International Classification:
A61K 31/404
C07D 209/76
A61K 9/16
A61K 9/48
C07D 209/70
Abstract:
Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.

St-246 Liquid Formulations And Methods

View page
US Patent:
20190038767, Feb 7, 2019
Filed:
Oct 11, 2018
Appl. No.:
16/157343
Inventors:
- Corvallis OR, US
Melialani A.C.L.S. ANDERSON - Corvallis OR, US
William WEIMERS - Corvallis OR, US
Gopi Krishna KASI - Lynnwood WA, US
N K Peter SAMUEL - Corvallis OR, US
Tove C. Bolken - Keizer OR, US
Dennis E. HRUBY - Albany OR, US
Assignee:
SIGA TECHNOLOGIES, INC. - Corvallis OR
International Classification:
A61K 47/69
A61K 31/715
A61K 31/724
A61K 9/08
A61K 47/40
A61K 9/00
A61K 31/4035
A61K 47/26
A61K 47/10
Abstract:
The present invention provides for a novel liquid formulation for solubilizing poorly soluble ST-246 in cyclodextrins and a novel process of making the formulation.

Polymorphic Forms Of St-246 And Methods Of Preparation

View page
US Patent:
20180311213, Nov 1, 2018
Filed:
Jul 2, 2018
Appl. No.:
16/025057
Inventors:
- Corvallis OR, US
Melialani A.C.L.S. ANDERSON - Corvallis OR, US
William C. WEIMERS - Corvallis OR, US
Dylan NELSON - Corvallis OR, US
Dennis E. HRUBY - Albany OR, US
Michael H. O'NEILL - Painesville OH, US
Gary SWEETAPPLE - Madison OH, US
Kelley A. McCLOUGHAN - South Haven MI, US
Assignee:
Siga Technologies, Inc. - Corvallis OR
International Classification:
A61K 31/404
C07D 209/76
A61K 9/16
A61K 9/48
C07D 209/70
Abstract:
Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.

Polymorphic Forms Of St-246 And Methods Of Preparation

View page
US Patent:
20180193308, Jul 12, 2018
Filed:
Jul 27, 2017
Appl. No.:
15/661194
Inventors:
- Corvallis OR, US
Melialani A.C.L.S. ANDERSON - Corvallis OR, US
William C. WEIMERS - Corvallis OR, US
Dylan NELSON - Corvallis OR, US
Dennis E. HRUBY - Albany OR, US
Michael H. O'NEILL - Painesville OH, US
Gary SWEETAPPLE - Madison OH, US
Kelley A. McCLOUGHAN - South Haven MI, US
Assignee:
Siga Technologies, Inc. - Corvallis OR
International Classification:
A61K 31/404
C07D 209/76
A61K 9/16
A61K 9/48
C07D 209/70
Abstract:
Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.
Melialani Athena Anderson from Corvallis, OR, age ~42 Get Report